Evidence map›Paper›PMID 20003392›Full record

ArticleBMC biotechnology2009

An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody.

M Enamul Kabir, Senthilkumar Krishnaswamy, Masahiko Miyamoto, Yasuhiro Furuichi, Tadazumi Komiyama

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Naïve Human Antibody Libraries for Infectious Diseases.Advances in experimental medicine and biology · 2017
    Review
  4. Bioprotective Role of Yeasts.Microorganisms · 2015
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M Enamul KabirDepartment of Biochemistry, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Higashijima, Niigata, Japan. enamul.kabir_2000@yahoo.com
Senthilkumar Krishnaswamy
Masahiko Miyamoto
Yasuhiro Furuichi
Tadazumi Komiyama
Niigata University of Pharmacy and Applied Life Sciences · JPGeneCare Research Institute (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhage-display panning is an integral part of biomedical research. Regular panning methods are sometimes complicated by inefficient detachment of the captured phages from the antigen-coated solid supports, which prompted us to modify. Here, we produce an efficient antigen-specific single chain fragment variable (scFv) antibody by using a target-related molecule that favored selection of recombinant antibodies.

resultsTo produce more selective and specific anti-idiotypic scFv-antibodies from a cDNA library, constructed from HM-1 killer toxin (HM-1)-neutralizing monoclonal antibodies (nmAb-KT), the method was modified by using an elution buffer supplemented with HM-1 that shares structural and functional similarities with the active site of the scFv antibody. Competitive binding of HM-1 to nmAb-KT allowed easy and quick dissociation of scFv-displayed phages from immobilized nmAb-KT to select specific anti-idiotypic scFv antibodies of HM-1. After modified panning, 80% clones (40/50) showed several times higher binding affinity to nmAb-KT than regular panning. The major populations (48%) of these clones (scFv K1) were genotypically same and had strong cytocidal activity against Saccharomyces and Candida species. The scFv K1 (K(d) value = 4.62 x 10(-8) M) had strong reactivity toward nmAb-KT, like HM-1 (K(d) value = 6.74 x 10(-9) M) as judged by SPR analysis.

conclusionThe scFv antibodies generated after modified subtractive panning appear to have superior binding properties and cytocidal activity than regular panning. A simple modification of the elution condition in the phage-display panning protocol makes a large difference in determining success. Our method offers an attractive platform to discover potential therapeutic candidates.

Indexed as

Peptide LibraryAmino Acid SequenceAntibodies, Anti-IdiotypicAntibodies, FungalAntibodies, ImmobilizedAntibodies, MonoclonalAntibody AffinityAntifungal AgentsCatalytic DomainCloning, MolecularDNA FingerprintingEnzyme-Linked Immunosorbent AssayKiller Factors, YeastMolecular Sequence DataRecombinant ProteinsSequence AlignmentAntibodies, Anti-IdiotypicAntibodies, FungalAntibodies, ImmobilizedAntibodies, MonoclonalAntifungal AgentsKiller Factors, YeastPeptide LibraryRecombinant ProteinsSingle-Chain Antibodies

Identifiers

PMID20003392
PMCPMC2801674
OpenAlexW2055414061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.